Kewalramani Reshma — SEC insider filings

SEC reporting owner CIK 1735944. 52 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers the 50 most recent of 52 filings on record, filed 2021-02-12 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)CEO & President, Director444 legs · 20,000 sh · $5,852,25929 legs · 186,088 sh · $81,560,30143
Ginkgo Bioworks Holdings, Inc. (DNA)Director6——11

Insider filings — Kewalramani Reshma

FiledFormIssuerReported transactionsSource
2026-11-104VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 11,866 @ $531.53EDGAR
2026-03-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 400 @ $479.75 · Sale (S): 120 @ $481.50 · Sale (S): 240 @ $482.84 · Sale (S): 2,510 @ $487.13 · Sale (S): 3,278 @ $488.27 · Sale (S): 460 @ $489.32 · +7 moreEDGAR
2026-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 4,981 @ $485.11EDGAR
2026-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 16,326 @ $0 · Tax withholding (F): 6,554 @ $483.75EDGAR
2026-02-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 13,041 @ $487.76EDGAR
2026-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 8,297 @ $468.41EDGAR
2026-01-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 26,972 @ $0 · Grant/award (A): 11,885 @ $0EDGAR
2025-08-074VERTEX PHARMACEUTICALS INC / MA (VRTX)Purchase (P): 4,290 @ $389.08 · Purchase (P): 5,710 @ $389.95EDGAR
2025-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 14,079 @ $479.61EDGAR
2025-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 9,386 @ $483.28EDGAR
2025-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 6,553 @ $463.46EDGAR
2025-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 19,015 @ $0EDGAR
2025-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 8,300 @ $467.98EDGAR
2025-02-064VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 29,118 @ $0 · Grant/award (A): 20,328 @ $0EDGAR
2024-11-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 15,198 @ $515EDGAR
2024-08-014VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 15,202 @ $505EDGAR
2024-07-244VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 15,202 @ $497EDGAR
2024-06-144Ginkgo Bioworks Holdings, Inc. (DNA)Option exercise (M): 105,263 · Option exercise (M): 105,263 (derivative)EDGAR
2024-05-294VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 1,565 @ $187.53 · Sale (S): 1,565 @ $457 · Option exercise (M): 1,565 (derivative) @ $0EDGAR
2024-05-224VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 15,202 @ $447EDGAR
2024-02-274VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 9,386 @ $431.79EDGAR
2024-02-214VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 9,359 @ $424.01 · Tax withholding (F): 7,019 @ $420.58EDGAR
2024-02-134VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 8,255 @ $422.74EDGAR
2024-02-084VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 14,516 @ $0 · Grant/award (A): 26,972 @ $0 · Grant/award (A): 20,327 @ $0EDGAR
2023-12-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 3,058 @ $155.57 · Option exercise (M): 14,077 @ $187.53 · Sale (S): 17,135 @ $407 · Option exercise (M): 3,058 (derivative) @ $0 · Option exercise (M): 14,077 (derivative) @ $0EDGAR
2023-12-154VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 5,098 @ $397EDGAR
2023-11-154VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 5,097 @ $377EDGAR
2023-07-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 7,828 @ $355EDGAR
2023-06-214Ginkgo Bioworks Holdings, Inc. (DNA)Grant/award (A): 105,263 (derivative) @ $0 · Grant/award (A): 139,860 (derivative) @ $0EDGAR
2023-05-014VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 1,611 @ $338.69 · Sale (S): 1,668 @ $339.43 · Sale (S): 38 @ $340.19EDGAR
2023-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 9,386 @ $289.12EDGAR
2023-02-224VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 9,359 @ $292.85EDGAR
2023-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,372 @ $294.33 · Tax withholding (F): 5,990 @ $298.26EDGAR
2023-02-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 12,388 @ $0 · Grant/award (A): 29,118 @ $0 · Grant/award (A): 26,972 @ $0EDGAR
2023-01-274VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 10,000 @ $315.05EDGAR
2022-11-104Ginkgo Bioworks Holdings, Inc. (DNA)Option exercise (M): 9,818 · Option exercise (M): 9,818 (derivative) @ $0EDGAR
2022-08-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 11,689 @ $305.06EDGAR
2022-07-214/AVERTEX PHARMACEUTICALS INC / MA (VRTX)Holdings only — no transactions reportedEDGAR
2022-06-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 11,689 @ $291.30EDGAR
2022-06-134Ginkgo Bioworks Holdings, Inc. (DNA)Grant/award (A): 70,921 @ $0 · Grant/award (A): 108,516 (derivative) @ $0EDGAR
2022-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 7,246 @ $227.86EDGAR
2022-02-224VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 8,584 @ $232.51EDGAR
2022-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,031 @ $237.74EDGAR
2022-02-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 9,800 @ $0 · Grant/award (A): 29,032 @ $0 · Grant/award (A): 29,117 @ $0EDGAR
2021-11-234Ginkgo Bioworks Holdings, Inc. (DNA)Grant/award (A): 9,818 (derivative) @ $0EDGAR
2021-09-204Ginkgo Bioworks Holdings, Inc. (DNA)Grant/award (A): 51,782 (derivative) @ $0 · Grant/award (A): 17,649 (derivative) @ $0EDGAR
2021-08-234VERTEX PHARMACEUTICALS INC / MA (VRTX)Purchase (P): 5,757 @ $195.14 · Purchase (P): 4,243 @ $196.34EDGAR
2021-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,898 @ $217.57EDGAR
2021-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,080 @ $211.75EDGAR
2021-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,962 @ $214.16EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1735944 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs